Emmons, Michael F.
Bennett, Richard L. http://orcid.org/0000-0002-0243-2443
Riva, Alberto http://orcid.org/0000-0001-9150-8333
Gupta, Kanchan
Carvalho, Larissa Anastasio Da Costa http://orcid.org/0000-0001-5720-5910
Zhang, Chao
Macaulay, Robert http://orcid.org/0000-0003-1115-3654
Dupéré-Richér, Daphne
Fang, Bin http://orcid.org/0000-0002-7636-1318
Seto, Edward
Koomen, John M. http://orcid.org/0000-0002-3818-1762
Li, Jiannong
Chen, Y. Ann http://orcid.org/0000-0003-1468-3490
Forsyth, Peter A. http://orcid.org/0000-0002-3756-8594
Licht, Jonathan D. http://orcid.org/0000-0002-3942-1369
Smalley, Keiran S. M. http://orcid.org/0000-0003-1089-9307
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01 CA262483, R21 CA267141, P30 CA076292)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | National Institutes of Health (CA262483, P30 CA247796)
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 24 August 2022
Accepted: 13 November 2023
First Online: 29 November 2023
Competing interests
: P.A.F. serves on advisory boards for AbbVie Inc., Bristol-Myers Squibb, Boehringer-Ingelheim, NCI Neuro-Oncology Branch Peer Review, NCRI, NIH, Novellus, Physical Sciences Oncology Network, Tocagen (not active), Ziopharm, National Brain Tumor Society and as a consultant for Bayer, BTG, GlaxoSmithKline (GSK), Inovio, and Novocure. KSMS receives grant funding from Revolution Medicines and honoraria from Elsevier unrelated to the current study. J.M.K. receives salary support from BMS. The remaining authors declare no conflict of interest.